Selective serotonin reuptake inhibitors are linked to symptoms ranging from yawning and hyperhidrosis to increased bleeding risk.
MADRID – Ultrasound helps identify subset of fistulae that respond well to medication alone.
From the Journals
New meta-analysis comes with a large caveat about “high heterogeneity of the included studies.”
MADRID – Definitive evidence of the drug’s efficacy and safety must await the results of the pivotal phase 3 PEGASUS trial.
Make the Diagnosis
A 72-year-old male presented with a year-long history of a progressive, pruritic eruption consisting of firm, skin-colored papules on his head and...
Interleukin-4 receptors, directly targeted by dupilumab, were highly up-regulated in keloid lesions, compared with controls.
MADRID – Reassuring results of a long-term extension of the phase 3 RELIEF trial.
LAS VEGAS – Disorder can strike patients with diabetes who inject themselves frequently.
BOSTON – PPAR agonist now warrants consideration as first-line treatment for “vexing” clinical issue.
LAS VEGAS – Even the use of antiperspirants should come with guidance.
LAS VEGAS – Watch out for unexpected secondary causes of hyperhidrosis, said Dr. Seemal R. Desai.